Search research articles
Contact Us
Filters
Showing results (21-30 of 49) with videos related to
Page
of 5
Sort By:
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|
January 30, 2009
A comparison of ziprasidone and risperidone in the long-term treatment of schizophrenia: a 44-week, double-blind, continuation study
Donald E Addington, Alain Labelle, Jayashri Kulkarni, et al.
Journal of Clinical Psychopharmacology
|
January 19, 2002
Double-blind, placebo-controlled comparison of the efficacy of sertraline as treatment for a major depressive episode in patients with remitted schizophrenia
Donald Addington, Jean Addington, Scott Patten, et al.
Journal of Psychopharmacology (Oxford, England)
|
March 17, 2023
An α7 nAChR approach for the baseline-dependent modulation of deviance detection in schizophrenia: A pilot study assessing the combined effect of CDP-choline and galantamine
Joëlle Choueiry, Crystal M Blais, Dhrasti Shah, et al.
Schizophrenia Research
|
July 12, 2005
Increased prevalence of schizophrenia spectrum disorders in relatives of neuroleptic-nonresponsive schizophrenic patients
Ridha Joober, Guy A Rouleau, Samarthji Lal, et al.
International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology
|
February 22, 2019
Combining CDP-choline and galantamine, an optimized α7 nicotinic strategy, to ameliorate sensory gating to speech stimuli in schizophrenia
Joelle Choueiry, Crystal M Blais, Dhrasti Shah, et al.
Frontiers in Behavioral Neuroscience
|
March 28, 2014
Structural hippocampal anomalies in a schizophrenia population correlate with navigation performance on a wayfinding task
Andrée-Anne Ledoux, Patrice Boyer, Jennifer L Phillips, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
|
March 16, 2013
Auditory verbal hallucinations in schizophrenia correlate with P50 gating
Dylan M Smith, Bryan Grant, Derek J Fisher, et al.
Psychiatry Research
|
January 29, 2013
Decreased fMRI activity in the hippocampus of patients with schizophrenia compared to healthy control participants, tested on a wayfinding task in a virtual town
Andrée-Anne Ledoux, Jennifer Lynne Phillips, Alain Labelle, et al.
International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology
|
July 14, 2011
Effects of auditory hallucinations on the mismatch negativity (MMN) in schizophrenia as measured by a modified 'optimal' multi-feature paradigm
Derek J Fisher, Bryan Grant, Dylan M Smith, et al.
Psychiatry Research
|
March 20, 2012
Nicotine and the hallucinating brain: effects on mismatch negativity (MMN) in schizophrenia
Derek J Fisher, Bryan Grant, Dylan M Smith, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 49) with videos related to
Sort By:
Page
of 5
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|
January 30, 2009
A comparison of ziprasidone and risperidone in the long-term treatment of schizophrenia: a 44-week, double-blind, continuation study
Donald E Addington, Alain Labelle, Jayashri Kulkarni, et al.
Journal of Clinical Psychopharmacology
|
January 19, 2002
Double-blind, placebo-controlled comparison of the efficacy of sertraline as treatment for a major depressive episode in patients with remitted schizophrenia
Donald Addington, Jean Addington, Scott Patten, et al.
Journal of Psychopharmacology (Oxford, England)
|
March 17, 2023
An α7 nAChR approach for the baseline-dependent modulation of deviance detection in schizophrenia: A pilot study assessing the combined effect of CDP-choline and galantamine
Joëlle Choueiry, Crystal M Blais, Dhrasti Shah, et al.
Schizophrenia Research
|
July 12, 2005
Increased prevalence of schizophrenia spectrum disorders in relatives of neuroleptic-nonresponsive schizophrenic patients
Ridha Joober, Guy A Rouleau, Samarthji Lal, et al.
International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology
|
February 22, 2019
Combining CDP-choline and galantamine, an optimized α7 nicotinic strategy, to ameliorate sensory gating to speech stimuli in schizophrenia
Joelle Choueiry, Crystal M Blais, Dhrasti Shah, et al.
Frontiers in Behavioral Neuroscience
|
March 28, 2014
Structural hippocampal anomalies in a schizophrenia population correlate with navigation performance on a wayfinding task
Andrée-Anne Ledoux, Patrice Boyer, Jennifer L Phillips, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
|
March 16, 2013
Auditory verbal hallucinations in schizophrenia correlate with P50 gating
Dylan M Smith, Bryan Grant, Derek J Fisher, et al.
Psychiatry Research
|
January 29, 2013
Decreased fMRI activity in the hippocampus of patients with schizophrenia compared to healthy control participants, tested on a wayfinding task in a virtual town
Andrée-Anne Ledoux, Jennifer Lynne Phillips, Alain Labelle, et al.
International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology
|
July 14, 2011
Effects of auditory hallucinations on the mismatch negativity (MMN) in schizophrenia as measured by a modified 'optimal' multi-feature paradigm
Derek J Fisher, Bryan Grant, Dylan M Smith, et al.
Psychiatry Research
|
March 20, 2012
Nicotine and the hallucinating brain: effects on mismatch negativity (MMN) in schizophrenia
Derek J Fisher, Bryan Grant, Dylan M Smith, et al.
Page
of 5